Home

JEAN DELEAGE

CIK 1198323 · last filed 2010-05-28

JEAN DELEAGE is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for RIGL, was dated May 28, 2010. 48 SEC filings were submitted jointly with GUY P NOHRA.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

14

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
ONE EMBARCADERO CENTER SUITE 3700
SAN FRANCISCO, CA 94111
Related Filers
GUY P NOHRA — 48 joint filings, latest 2011-02-18
GARRETT GRUENER — 47 joint filings, latest 2009-09-08
ALTA PARTNERS — 34 joint filings, latest 2009-09-08
FARAH CHAMPSI — 24 joint filings, latest 2010-10-27
DANIEL JANNEY — 19 joint filings, latest 2011-02-18
ALTA BIOPHARMA PARTNERS III LP — 13 joint filings, latest 2010-10-27
EDWARD PENHOET — 13 joint filings, latest 2010-10-27
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG — 9 joint filings, latest 2010-10-27
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RIGL Director — $47.03 — $0 4 2010-05-28
KOSAN BIOSCIENCES INC (KOSN) Delisted Director 0 — — $0 5 2008-06-27
IDM PHARMA, INC. (IDMI) Delisted Director 2,673 — — $0 3 2007-06-20

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2010-05-28 RIGL Grant (A) — $0 EDGAR
2009-05-29 RIGL Grant (A) — $0 EDGAR
2008-06-27 KOSAN BIOSCIENCES INC (KOSN) Delisted Mixed −1,653,566 -$9.09M EDGAR
2008-06-20 — Grant (A) — $0
2008-06-13 KOSAN BIOSCIENCES INC (KOSN) Delisted Grant (A) — $0 EDGAR
2008-05-30 KOSAN BIOSCIENCES INC (KOSN) Delisted Grant (A) — $0 EDGAR
2008-05-30 RIGL Grant (A) — $0 EDGAR
2008-05-28 KOSAN BIOSCIENCES INC (KOSN) Delisted Grant (A) — $0 EDGAR
2007-06-20 IDM PHARMA, INC. (IDMI) Delisted Grant (A) — $0 EDGAR
2007-06-01 RIGL Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.